Holen Sie sich die Stockscreener-App
0.5515
2.32%
-0.0131
Handel nachbörslich:
.56
0.0085
+1.54%
Schlusskurs vom Vortag:
$0.5646
Offen:
$0.58
24-Stunden-Volumen:
1.38M
Relative Volume:
0.74
Marktkapitalisierung:
$74.97M
Einnahmen:
$46.74M
Nettoeinkommen (Verlust:
$-114.33M
KGV:
-0.9173
EPS:
-0.6012
Netto-Cashflow:
$-21.04M
1W Leistung:
-18.90%
1M Leistung:
-43.72%
6M Leistung:
-50.32%
1J Leistung:
-41.80%
1-Tages-Spanne:
$0.5451
$0.5831
1-Wochen-Bereich:
$0.5377
$0.7348
52-Wochen-Spanne:
$0.5377
$2.63
Scilex Holding Company Stock (SCLX) Company Profile
Firmenname
Scilex Holding Company
Sektor
Telefon
(650) 516-4310
Adresse
960 SAN ANTONIO ROAD, PALO ALTO
Vergleichen Sie SCLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| SCLX | 0.5515 | 74.97M | 46.74M | -114.33M | -21.04M | -0.6012 |
| LLY | 749.92 | 703.67B | 40.86B | 8.37B | -2.28B | 5.4193 |
| NVO | 102.63 | 455.01B | 39.36B | 13.79B | 9.83B | 2.4077 |
| JNJ | 155.50 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 171.73 | 296.46B | 55.53B | 5.12B | 15.62B | 3.65 |
| MRK | 99.86 | 248.45B | 63.17B | 12.15B | 14.84B | 1.80 |
Scilex Holding Company Aktie (SCLX) Neueste Nachrichten
Sciatica Market | Sciatica Therapies, Clinical trials, Sciatica prevalence, Sciatica Treatment, Sciatica Companies | Scilex Holding Company, Seikagaku Corporation, Sollis Therapeutics, SpineThera, Kol - The Globe and Mail
Open Text Corp (OTEX-Q) QuotePress Release - The Globe and Mail
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 1419, 2024 - The Manila Times
Scilex Holding Company Announces Presentation of Data at - GlobeNewswire
Scilex Holding Company Announces Presentation of Data at the 2024 American College of ... - The Bakersfield Californian
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024 - Yahoo Finance
Private companies who have a significant stake must be disappointed along with institutions after Scilex Holding Company's (NASDAQ:SCLX) market cap dropped by US$22m - Simply Wall St
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Pre - The Manila Times
Scilex Holding Plans Merger to Boost Semnur Value - TipRanks
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of - GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces - The Bakersfield Californian
Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary - Barchart
Boeing Company (BA-N) QuotePress Release - The Globe and Mail
Chipotle Mexican Grill (CMG-N) QuotePress Release - The Globe and Mail
Scilex Pharmaceuticals announces end of phase II meeting with FDA for SP-103 - MSN
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares - Investing.com India
A W Food Services of Canada Inc (AW-T) QuotePress Release - The Globe and Mail
Pleasing Signs As A Number Of Insiders Buy Scilex Holding Stock - Yahoo Finance
Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, - The Manila Times
Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of - GlobeNewswire
Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares By Investing.com - Investing.com Canada
Jaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat
Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock - ForexTV.com
Scilex Holding Company, Following its Prior Announcement of - GlobeNewswire
Scilex Holding Sets Dividend for Preferred Stock Exchange - TipRanks
Scilex Holding Company sets November 7, 2024 as the Record - GlobeNewswire
Alliance Global Partners Begins Coverage on Scilex (NASDAQ:SCLX) - Defense World
Scilex gains on spinoff plans for pharma subsidiary - MSN
Scilex director Followwill Dorman buys $990 in common stock By Investing.com - Investing.com South Africa
Scilex director Followwill Dorman buys $990 in common stock - Investing.com
Scilex director Chun Jay acquires $4,750 in common stock - Investing.com
Holding Company Shares Rally Following Board Of Directors Commentary - MSN
Scilex Holding (NASDAQ:SCLX) Director Yue Alexander Wu Acquires 20,000 Shares - MarketBeat
Scilex holding's executive chairperson Ji Henry buys $9,710 in stock - Investing.com
Scilex director Wu Yue Alexander buys $18,992 in common stock By Investing.com - Investing.com South Africa
Scilex director Wu Yue Alexander buys $18,992 in common stock - Investing.com India
Scilex holding's executive chairperson Ji Henry buys $9,710 in stock By Investing.com - Investing.com UK
Scilex director Chun Jay acquires $4,750 in common stock By Investing.com - Investing.com Australia
Scilex CFO Stephen Hoi purchases $6,499 in common stock - Investing.com India
Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock - Investing.com India
Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock By Investing.com - Investing.com Canada
Jaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat
Scilex CFO Stephen Hoi purchases $6,499 in common stock By Investing.com - Investing.com UK
Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate - Benzinga
TSX Energy Capped Index (TTEN) QuotePress Release - The Globe and Mail
Scilex Holding looks to separate Scilex Pharma through potential spinout, IPO - FiercePharma
Scilex stock gains on spinoff plans (SCLX:NASDAQ) - Seeking Alpha
Scilex Holding explores spinoff for subsidiary Scilex Pharma - Investing.com
Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of securit - The Manila Times
Scilex Holding explores spinoff for subsidiary Scilex Pharma By Investing.com - Investing.com South Africa
Finanzdaten der Scilex Holding Company-Aktie (SCLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):